RecruitingNCT05072626
High Medium-chain Triglyceride Nutritional Support in Infants With Biliary Atresia
Study on High Medium-chain Triglyceride Nutritional Support in Infants With Biliary Atresia After Kasai Portoenterostomy
Sponsor
Children's Hospital of Fudan University
Enrollment
300 participants
Start Date
Oct 11, 2021
Study Type
OBSERVATIONAL
Conditions
Summary
This study is a prospective, single center and observational open clinical study.
Eligibility
Max Age: 3 Months
Inclusion Criteria1
- The Kasai procedure for infants with biliary atresia under the age of 3 months.
Exclusion Criteria2
- Complicated with cirrhosis, hepatitis, or other hepatic disorders;
- Complicated with other systemic serious diseases (such as congenital multiple malformations, chromosome abnormalities)
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05072626
Related Trials
Preoperative Serum FGF19 in the Prognosis of Biliary Atresia
NCT058483101 location
Optimizing Tracheal Intubation Outcomes and Neonatal Safety
NCT058386908 locations
The Use of Near-Infrared Fluorescence Cholangiography With Indocyanine Green (ICG) in the Work Up of Neonatal Cholestasis
NCT072508541 location
Nutritional Intervention for Biliary Atresia
NCT067640821 location
Outpatient Pediatric Pulse Oximeters in Africa
NCT059143241 location